Lipocine (LPCN) Tops Q1 EPS by 66c

Lipocine (NASDAQ: LPCN) reported Q1 EPS of $0.66. Revenue for the quarter came in at $7.62 million.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ennis (EBF) Reports In-Line Q1 EPS
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance